Shire to Conduct Trials on Vyvanse on FDA’s Request

Shire plc (SHPG) announced that it has agreed to conduct pediatric clinical studies following FDA's request to investigate the potential use of Vyvanse for the treatment of ADHD in children aged between …

from Content Keyword RSS http://ift.tt/1mTeqdr http://ift.tt/eA8V8J

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s